S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
CVE:LBL

Lattice Biologics Insider Trades

C$0.06
0.00 (0.00 %)
(As of 02/26/2021 02:43 PM ET)
Add
Compare
Today's Range
C$0.06
Now: C$0.06
C$0.06
50-Day Range
C$0.00
MA: C$0.07
C$0.13
52-Week Range
C$0.02
Now: C$0.06
C$0.21
Volume230,513 shs
Average Volume882,999 shs
Market CapitalizationC$7.69 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Insider Trades

Lattice Biologics (CVE:LBL) Insider Buying and Selling Activity

Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

Insider Buying and Selling by Quarter


Lattice Biologics (CVE LBL) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2018Cheryl FarmerDirectorBuy10,000C$0.04C$400.00
7/10/2018Cheryl FarmerDirectorBuy10,000C$0.06C$600.00
6/29/2018Cheryl FarmerDirectorBuy1,000C$0.07C$70.00
6/15/2018Cheryl FarmerDirectorBuy1,500C$0.08C$120.00
6/11/2018Cheryl FarmerDirectorBuy500C$0.07C$35.00
6/7/2018Cheryl FarmerDirectorBuy10,000C$0.05C$500.00
6/4/2018Cheryl FarmerDirectorBuy10,000C$0.06C$600.00
5/22/2018Cheryl FarmerDirectorBuy20,000C$0.05C$1,000.00
5/2/2017Mario StifanoDirectorBuy2,600C$0.18C$468.00
3/8/2017Mario StifanoDirectorBuy2,000C$0.23C$460.00
1/30/2017Mario StifanoDirectorBuy2,000C$0.29C$580.00
9/7/2016Mario StifanoDirectorBuy3,800C$0.25C$950.00
8/8/2016Mario StifanoDirectorBuy2,000C$0.27C$540.00
3/16/2016Mario StifanoDirectorBuy300C$0.26C$78.00
2/24/2016Mario StifanoDirectorBuy1,000C$0.25C$250.00
2/23/2016Mario StifanoDirectorBuy8,200C$0.23C$1,886.00
2/19/2016Mario StifanoDirectorBuy1,000C$0.25C$245.00
2/18/2016Mario StifanoDirectorBuy400C$0.28C$110.00
2/17/2016Mario StifanoDirectorBuy2,000C$0.28C$550.00
2/12/2016Mario StifanoDirectorBuy1,000C$0.28C$275.00
1/26/2016Mario StifanoDirectorBuy2,000C$0.29C$580.00
1/12/2016Mario StifanoDirectorBuy2,000C$0.33C$660.00
(Data available from 1/1/2013 forward)
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.